Effects of intra-articular injection of ropivacaine plus compound betamethasone after arthroscopic debridement for knee osteoarthritis
10.3760/cma.j.issn.0254-9026.2012.06.020
- VernacularTitle:关节镜术后联合罗哌卡因和复方倍他米松治疗膝关节骨性关节炎的疗效观察
- Author:
Yi YUAN
;
Haijun ZHANG
;
Qinjiang PANG
;
Bo ZHANG
- Publication Type:Journal Article
- Keywords:
Knee joint;
Osteoarthritis;
Arthroscopy;
Anesthetics,local;
Betamethasone
- From:
Chinese Journal of Geriatrics
2012;31(6):510-512
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effects of intra-articular injection of ropivacaine plus compound betamethasone after arthroscopic debridement for knee osteoarthritis.Methods A total of 164 patients with knee osteoarthritis after arthroscopic debridement were randomly divided into three groups:combination group (n=62) treated by 2 ml sodium hyaluronate and 0.75% ropivacaine of 5 ml plus 1 ml compound betamethasone,compound betamethasone group (n=54) by 2 ml sodium hyaluronate and 1 ml compound betamethasone,control group (n=48) by simply sodium hyaluronate.The Lequesne Index was used to evaluate the clinical effects before and 1 week,6 weeks and 12 weeks after operation.All patients received at least 12 weeks follow-up Results According to Lequesne Index score criteria,a significant decrease was found in all groups before versus after operation(P<0.05).The clinical effects in combination group and compound betamethasone group were more improved as compared with control group at 1,6 and 12 weeks after operation (P<0.05).The effect in combination group was better than compound betamethasone group at 1 and 6 weeks after operation,but not at 12 weeks (P>0.05).Conclusions The intra-articular injection of ropivacaine plus compound betamethasone after arthroscopic debridement is a good method for relieving pain and improving the knee function.